|
Volumn 78, Issue 2, 2004, Pages 283-285
|
Treatment of cytomegalovirus disease with valganciclovir in renal transplant recipients: a single center experience.
a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
DRUG DERIVATIVE;
GANCICLOVIR;
VALGANCICLOVIR;
ARTICLE;
CYTOMEGALIC INCLUSION BODY DISEASE;
HUMAN;
KIDNEY TRANSPLANTATION;
PHYSIOLOGY;
PILOT STUDY;
POSTOPERATIVE COMPLICATION;
RETROSPECTIVE STUDY;
VIROLOGY;
ANTIVIRAL AGENTS;
CYTOMEGALOVIRUS INFECTIONS;
GANCICLOVIR;
HUMANS;
KIDNEY TRANSPLANTATION;
PILOT PROJECTS;
POSTOPERATIVE COMPLICATIONS;
RETROSPECTIVE STUDIES;
|
EID: 3943066445
PISSN: 00411337
EISSN: None
Source Type: Journal
DOI: 10.1097/01.TP.0000128343.88355.14 Document Type: Article |
Times cited : (30)
|
References (0)
|